Despite a substantial body of evidence indicating an association between IL-23R single-nucleotide polymorphisms (SNPs) and the risk of inflammatory bowel disease (IBD) in independent patient cohorts, it is essential to acknowledge that some studies have not identified a correlation between IL-23R SNP variations and the likelihood of developing IBD. The gene discussed is IL23R; the disease is inflammatory bowel disease.